Digital Pathology Industry - Regional Synopsis
The market in North America is expected to dominate largest share by the end of 2037, backed by rising geriatric population in the region. It was estimated that the U.S. population aged above 65 years was recorded to be 54 million in the year 2019. Moreover, the increasing R&D investments, continuous government support for development in IT healthcare, growing acceptance of digital imaging, rising awareness of the early diagnosis of diseases among population and presence of key manufacturers in the region are expected to impel the market revenue.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of digital pathology is assessed at USD 1.39 billion.
The digital pathology market size was valued at USD 1.27 billion in 2024 and is likely to reach USD 5.14 billion by the end of 2037, registering around 11.3% CAGR during the forecast period i.e., between 2025-2037. Rising incidence of chronic and cardiovascular disease, growing geriatric population along with introduction of AI tools in healthcare will boost the market growth.
North America is anticipated to hold largest revenue share by 2037, driven by rising geriatric population in the region.
The major players in the market include ContextVision AB, Leica Biosystems Nussloch GmbH, GE Healthcare, Ventana Medical Systems Inc., Hamamatsu Photonics K.K., Apollo Enterprise Imaging Corporation, Xifin Inc., Definiens AG., Inspirata, Inc., 3DHISTECH Ltd.
